Evidence map›Paper›PMID 40813567›Full record

ArticleDalton transactions (Cambridge, England : 2003)2025

IPaul

Pamela Podchorodecka, Błażej Dziuk, Roman Szostak, Michal Szostak, Elwira Bisz

Abstract read
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. IPr*Dalton transactions (Cambridge, England : 2003) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pamela PodchorodeckaDepartment of Chemistry and Pharmacy, Opole University, 48 Oleska Street, Opole 45-052, Poland. ebisz@uni.opole.pl.
Błażej DziukDepartment of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, Wroclaw 50-373, Poland.
Roman SzostakDepartment of Chemistry, Wroclaw University, F. Joliot-Curie 14, Wroclaw 50-383, Poland.ORCID http://orcid.org/0000-0002-5436-7284
Michal SzostakDepartment of Chemistry, Rutgers University, 73 Warren Street, Newark, NJ 07102, USA. michal.szostak@rutgers.edu.ORCID http://orcid.org/0000-0002-9650-9690
Elwira BiszDepartment of Chemistry and Pharmacy, Opole University, 48 Oleska Street, Opole 45-052, Poland. ebisz@uni.opole.pl.ORCID http://orcid.org/0000-0002-7070-2468

Funding

Catalytic Methods for Organic SynthesisR35GM133326 · NIGMS · RUTGERS THE STATE UNIV OF NJ NEWARK · PI Michal Szostak · 2019 to 2026
$2.7M
NIGMS NIH HHS R35 GM133326
6 · The paper itself

Abstract

N-Heterocyclic carbenes (NHCs) are among the most versatile ligands in transition metal catalysis with their steric and electronic properties playing a critical role in governing reactivity and selectivity. In this area, the wingtip unsymmetrical IPaul ligand introduced by Nelson and co-workers offers a unique balance of steric bulk and flexibility characterized by spatially-defined steric features. Herein, we report a new class of IPaul-based ligands bearing benzoxazole and benzothiazole donor wingtips. The synthesis, application, and structural and electronic characterization are described. These ligands retain the defining 'bulky yet flexible' profile of IPaul, while enabling precise control over the catalytic pocket geometry through N-heteroaryl wingtip substitution. We present their coordination chemistry with Ag(I), Pd(II), Rh(I), and Se as well as catalytic studies in cross-coupling and hydrosilylation catalyzed by Ag, Pd, and Rh complexes. By combining the steric asymmetry of IPaul with the chelating flexibility of N-azole donors, this ligand class provides stabilization of reactive metal centers and is well-suited for diverse catalytic applications. We anticipate that the combination of steric flexibility with N,C-chelation in versatile N-heterocyclic carbenes will be of broad interest across organometallic, inorganic and catalytic chemistry.

Identifiers

PMID40813567
PMCPMC12360485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.